Department of Surgery, Medical Faculty Mannheim, Universitätsmedizin Mannheim, Heidelberg University, Mannheim, Germany.
Department of Digestive, Oncologic and Metabolic Surgery, Institute Mutualist of Montsouris, Paris, France.
World J Surg. 2022 Aug;46(8):1969-1979. doi: 10.1007/s00268-022-06572-3. Epub 2022 May 7.
There is no consensus on the pancreatic transection during distal pancreatectomy (DP) to reduce postoperative pancreatic fistula (POPF). This meta-analysis aimed to evaluate the effects of a reinforced stapler on the postoperative outcomes of DP.
We systematically searched electronic databases and bibliographic reference lists in The PubMed/MEDLINE, Google Scholar, Cochrane Library's Controlled Trials Registry and Database of Systematic Reviews, Embase, and Scopus. Review Manager Software was used for pooled estimates.
Seven eligible studies published between 2007 and 2021 were included with 553 patients (267 patients in the reinforced stapler group and 286 patients in the standard stapler group). The reinforced stapler reduced the POPF grade B and C (OR = 0.33; 95% CI [0.19, 0.57], p < 0.01). There was no difference between the reinforced stapler group and standard stapler group in terms of mortality rate (OR = 0.39; 95% CI [0.04, 3.57], p = 0.40), postoperative haemorrhage (OR = 0.53; 95% CI [0.20, 1.43], p = 0.21), and reoperation rate (OR = 0.91; 95% CI [0.40, 2.06], p = 0.82).
Reinforced stapling in DP is safe and seems to reduce POPF grade B/C with similar mortality rates, postoperative bleeding, and reoperation rate. The protocol of this systematic review with meta-analysis was registered in PROSPERO (ID: CRD42021286849).
在胰体尾切除术(DP)中,对于减少术后胰瘘(POPF)的胰腺横断术尚无共识。本荟萃分析旨在评估加强吻合器对 DP 术后结果的影响。
我们系统地检索了 The PubMed/MEDLINE、Google Scholar、Cochrane Library's Controlled Trials Registry and Database of Systematic Reviews、Embase 和 Scopus 电子数据库以及参考文献列表。使用 Review Manager 软件进行汇总估计。
纳入了 2007 年至 2021 年期间发表的 7 项符合条件的研究,共纳入 553 名患者(强化吻合器组 267 名,标准吻合器组 286 名)。强化吻合器可降低 POPF 分级 B 和 C(OR=0.33;95%CI[0.19,0.57],p<0.01)。强化吻合器组与标准吻合器组在死亡率(OR=0.39;95%CI[0.04,3.57],p=0.40)、术后出血(OR=0.53;95%CI[0.20,1.43],p=0.21)和再次手术率(OR=0.91;95%CI[0.40,2.06],p=0.82)方面无差异。
在 DP 中使用强化吻合器是安全的,似乎可以降低 POPF 分级 B/C,且死亡率、术后出血和再次手术率相似。本系统评价和荟萃分析的方案已在 PROSPERO(ID:CRD42021286849)中注册。